3VR]/W0PV^MV]^Y0&A0OG%59O%<WUY?>.9T5
SYSTEM PROCESSING...
3VR]/W0PV^MV]^Y0&A0OG%59O%<WUY?>.9T5
SYSTEM PROCESSING...
Posted: 2025-04-17 16:22:38 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-17 16:22:57 UTC
Verified By
Rollup News
The April 17, 2025 issue of NEJM features research articles on Obinutuzumab in Active Lupus Nephritis, Tecovirimat for Endemic Mpox, Pulsed Field or Cryoballoon Ablation for AF, and Fidanacogene Elaparvovec for Hemophilia.
Obinutuzumab for lupus nephritis
Tecovirimat for mpox treatment
AF ablation techniques
Gene therapy for hemophilia
Lack of evidence for tecovirimat efficacy
Managing lupus nephritis
Treating endemic mpox
Advancements in AF ablation
Gene therapy for hemophilia